đź’¨ Abstract
Xencor Inc. (XNCR), a biotech based in Pasadena, reported a $48.4 million loss and a 66 cents per share loss for Q1 2025, missing Wall Street's loss expectations of 63 cents per share. However, its revenue of $32.7 million exceeded the forecasted $22.1 million.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Man City’s surprising draw at Southampton throws Champions League hopes into doubt -
Louisiana governor pushes Trump to weigh primary challenger to GOP Sen. Bill Cassidy, AP sources say -
Lista completa: estos son los nombres de bebés más populares en EEUU
Multiple explosions heard in Indian-controlled Kashmir hours after India and Pakistan said they would stop fighting -
Tarling wins Giro stage 2 by a second over new overall leader Roglic -
Bochum and Holstein Kiel relegated from Bundesliga and Leipzig fails to reach Champions League -
As cardinal, Pope Leo XIV balanced the sacramental with the personal while confirming teenagers -
Los republicanos de la Cámara de Representantes impulsan recortes a las pensiones -
Fire at chemical plant in northeastern Spain keeps thousands indoors -
Saints QB Derek Carr is retiring because of a degenerative condition in his right shoulder -
Powered by MessengerX.io